How viral sequence analysis may guide development of RSV monoclonal antibodies.
暂无分享,去创建一个
[1] O. Ramilo,et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. , 2018, The Lancet. Infectious diseases.
[2] Hui Liu,et al. Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States , 2018, PloS one.
[3] B. Earp. The need for reporting negative results - a 90 year update , 2017, Journal of clinical and translational research.
[4] M. Jit,et al. Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England , 2017, The Lancet. Public health.
[5] K. Poehling,et al. The burden of respiratory syncytial virus infection in young children. , 2009, The New England journal of medicine.